Bridgeway Capital Management, LLC T2 Biosystems, Inc. Transaction History

Bridgeway Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.86 - $1.21 $258,000 - $363,000	-300,000 Reduced 51.49%	282,600 $259,000
Q2 2021 Aug 16, 2021	SELL	$1.04 - $1.69 $44,096 - $71,656	-42,400 Reduced 6.78%	582,600 $693,000
Q1 2021 May 17, 2021	BUY	$1.32 - $3.79 $462,000 - $1.33 Million	350,000 Added 127.27%	625,000 $1.01 Million
Q4 2020 Feb 16, 2021	SELL	$1.06 - $1.51 $137,482 - $195,847	-129,700 Reduced 32.05%	275,000 $341,000
Q2 2020 Aug 14, 2020	BUY	$0.48 - $1.67 $120,000 - $417,500	250,000 Added 161.6%	404,700 $514,000
Q4 2019 Feb 14, 2020	BUY	$0.96 - $2.94 $4,512 - $13,818	4,700 Added 3.13%	154,700 $181,000
Q4 2017 Feb 14, 2018	SELL	$3.73 - $4.6 $320,407 - $395,139	-85,900 Reduced 36.41%	150,000 $618,000
Q3 2017 Nov 14, 2017	BUY	$3.9 - $6.78 $920,010 - $1.6 Million	235,900	235,900 $991,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.88M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.